UBS Reiterates Neutral Rating on Astera Labs, Inc. Common Stock (ALAB)

Market Context

Astera Labs, Inc. Common Stock operates in the Technology sector. The stock currently trades at $455.96 with a market capitalization of $20.2B. The stock has gained 408.7% over the past 52 weeks.

Analyst coverage from UBS provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Astera Labs, Inc. Common Stock.

Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.

Recent Analyst Activity for Astera Labs, Inc. Common Stock

Among the 10 most recent ratings: 6 Buy, 4 Hold, 0 Sell.

Date	Firm	Rating	Price Target
Jun 29, 2026	UBS	Neutral	N/A
Jun 24, 2026	Stifel	Buy	N/A
Jun 23, 2026	B of A Securities	Neutral	N/A
May 19, 2026	Evercore ISI Group	Outperform	N/A
May 07, 2026	Barclays	Equal-Weight	N/A

Related Tools: Analyst Ratings Dashboard | View ALAB Stock Page